JL-14001

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NameJL-14001
Drug Alias NameJL14001JL-14001
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemiaRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJieku (Shanghai) Biomedical Research Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJieku (Shanghai) Biomedical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemiaRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A